Houston, TX, United States of America

Lucila Nassif Kerbauy

This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucila Nassif Kerbauy. Retrieved from https://idiyas.com/inventor/lucila-nassif-kerbauy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lucila Nassif Kerbauy: Innovator in Cancer Treatment

Introduction

Lucila Nassif Kerbauy is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 2 patents, her work focuses on the activation and expansion of natural killer (NK) cells, which play a crucial role in the immune response against cancer.

Latest Patents

Lucila's latest patents include groundbreaking methods for the activation and expansion of natural killer cells. These methods provide a way to pre-activate and expand an isolated population of NK cells. Furthermore, they outline techniques for treating cancer by administering these pre-activated and expanded NK cells, showcasing her commitment to advancing cancer therapies.

Career Highlights

Lucila is affiliated with the University of Texas System, where she continues her research and development in immunotherapy. Her work has garnered attention for its potential to improve cancer treatment outcomes and enhance patient care.

Collaborations

Lucila collaborates with Katy Rezvani, a fellow researcher in the field. Their partnership exemplifies the importance of teamwork in scientific advancements and the pursuit of innovative solutions to complex medical challenges.

Conclusion

Lucila Nassif Kerbauy stands out as an influential inventor in the realm of cancer treatment. Her innovative methods for NK cell activation and expansion represent a significant step forward in immunotherapy. Through her work at the University of Texas System, she continues to contribute to the fight against cancer, making a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…